Herbalife (NYSE:HLF) Director Sophie L’helias Buys 1,200 Shares

Herbalife Ltd (NYSE:HLF) Director Sophie L’helias acquired 1,200 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The shares were purchased at an average price of $11.31 per share, with a total value of $13,572.00. Following the completion of the acquisition, the director owned 79,882 shares of the company’s stock, valued at $903,465.42. This represents a 1.53% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Herbalife Price Performance

Herbalife stock opened at $11.39 on Friday. The company has a market capitalization of $1.18 billion, a price-to-earnings ratio of 5.00, a PEG ratio of 0.68 and a beta of 0.88. Herbalife Ltd has a one year low of $7.43 and a one year high of $20.40. The company’s fifty day moving average price is $14.36 and its two-hundred day moving average price is $14.83.

Herbalife (NYSE:HLF) last posted its earnings results on Wednesday, May 6th. The company reported $0.64 EPS for the quarter, topping the consensus estimate of $0.61 by $0.03. The firm had revenue of $1.32 billion for the quarter, compared to the consensus estimate of $1.30 billion. Herbalife had a net margin of 4.67% and a negative return on equity of 41.47%. The business’s quarterly revenue was up 7.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.59 earnings per share. As a group, sell-side analysts anticipate that Herbalife Ltd will post 2.47 earnings per share for the current year.

Institutional Investors Weigh In On Herbalife

Several hedge funds and other institutional investors have recently made changes to their positions in HLF. Optimize Financial Inc acquired a new stake in Herbalife during the third quarter worth about $511,000. GSA Capital Partners LLP acquired a new stake in Herbalife during the third quarter worth about $911,000. CenterBook Partners LP acquired a new stake in Herbalife during the third quarter worth about $368,000. Picton Mahoney Asset Management acquired a new stake in Herbalife during the third quarter worth about $898,000. Finally, Invenomic Capital Management LP acquired a new stake in Herbalife during the third quarter worth about $3,550,000.

Wall Street Analysts Forecast Growth

HLF has been the topic of several analyst reports. Weiss Ratings downgraded shares of Herbalife from a “hold (c+)” rating to a “hold (c)” rating in a research report on Friday, May 22nd. Wall Street Zen raised shares of Herbalife from a “buy” rating to a “strong-buy” rating in a research report on Saturday, April 18th. Mizuho set a $17.00 target price on shares of Herbalife in a research report on Monday, May 4th. Royal Bank Of Canada lowered their target price on shares of Herbalife from $17.00 to $16.00 and set a “sector perform” rating on the stock in a research report on Tuesday, April 28th. Finally, Zacks Research downgraded Herbalife from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 20th. Three equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, Herbalife currently has an average rating of “Hold” and an average price target of $17.80.

Herbalife Company Profile

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.